Evidence map›Paper›PMID 29088075›Full record

ReviewAntioxidants (Basel, Switzerland)2017

Effects of Cocoa Antioxidants in Type 2 Diabetes Mellitus.

Sonia Ramos, María Angeles Martín, Luis Goya

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Enrichment of dark chocolate with vitamin DJournal of food science and technology · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Chocolate, "Food of the Gods": History, Science, and Human Health.International journal of environmental research and public health · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sonia RamosDepartment of Metabolism and Nutrition. Institute of Food Science and Technology and Nutrition (ICTAN-CSIC). José Antonio Novais 10. Ciudad Universitaria, 28040 Madrid, Spain. s.ramos@ictan.csic.es.ORCID 0000-0003-2649-2616
María Angeles MartínDepartment of Metabolism and Nutrition. Institute of Food Science and Technology and Nutrition (ICTAN-CSIC). José Antonio Novais 10. Ciudad Universitaria, 28040 Madrid, Spain. amartina@ictan.csic.es.
Luis GoyaDepartment of Metabolism and Nutrition. Institute of Food Science and Technology and Nutrition (ICTAN-CSIC). José Antonio Novais 10. Ciudad Universitaria, 28040 Madrid, Spain. luisgoya@ictan.csic.es.
Instituto de Ciencia y Tecnología de Alimentos y Nutrición · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 Diabetes mellitus (T2D) is the most common form of diabetes and one of the most common chronic diseases. Control of hyperglycaemia by hypoglycaemic drugs is insufficient in for patients and nutritional approaches are currently being explored. Natural dietary compounds such as flavonoids, abundant in fruits and vegetables, have received broad attention because of their potential capacity to act as anti-diabetic agents. Especially cocoa flavonoids have been proved to ameliorate important hallmarks of T2D. In this review, an update of the most relevant reports published during the last decade in cell culture, animal models and human studies is presented. Most results support an anti-diabetic effect of cocoa flavonoids by enhancing insulin secretion, improving insulin sensitivity in peripheral tissues, exerting a lipid-lowering effect and preventing the oxidative and inflammatory damages associated to the disease. While it could be suggested that daily consumption of flavanols from cocoa or dark chocolate would constitute a potential preventive tool useful for the nutritional management of T2D, this recommendation should be cautious since most of commercially available soluble cocoa products or chocolates contain low amount of flavanols and are rich in sugar and calories that may aggravate glycaemic control in T2D patients.

Indexed as

beta cellcocoa flavonoidsflavanolshyperglycaemiainsulin resistanceprocyanidins

Identifiers

PMID29088075
PMCPMC5745494
OpenAlexW2766859044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.